SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-005856
Filing Date
2019-04-05
Accepted
2019-04-05 16:25:17
Documents
3
Period of Report
2019-04-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k040419_bioytran.htm 8-K 25810
2 LICENSE AGREEMENT BETWEEN BIOXYTRAN, INC. AND MDX LIFESCIENCES, INC. DATED APRIL f8k040419ex10-22_bioytran.htm EX-10.22 61646
3 PRESS RELEASE DATED APRIL 4, 2019. f8k040419ex99-1_bioytran.htm EX-99.1 11979
  Complete submission text file 0001213900-19-005856.txt   100946
Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 19735419
SIC: 2834 Pharmaceutical Preparations